SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Nome Químico: 6α,9-difluoro-11β,17,21-trihydroxy-pregna-1,4-diene-3,20-dione
Sinônimo: 6α,9-Difluoroprednisolone
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: F[C@@]1([C@]2(C=C3)C)[C@](C[C@H](F)C2=CC3=O)([H])[C@@](CC[C@]4(O)C(CO)=O)([H])[C@]4(C)C[C@@H]1O
6α,9α-Difluoroprednisolone is chemically 6α,9-difluoro-11β,17,21-trihydroxy-pregna-1,4-diene-3,20-dione. It is also known as 6α,9-Difluoroprednisolone. 6α,9α-Difluoroprednisolone is supplied with detailed characterization data compliant with regulatory guideline. 6α,9α-Difluoroprednisolone can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Prednisolone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Validated stability indicating RP-LC assay for determination of gatifloxacin and prednisolone acetatein ophthalmic preparations and biological samples
By Qadir, Muhammad A.; Shahzad, Shabnam; Ahmed, Mahmood; Razzaq, Syed S.; Shafiq, Muhmmad I.
From Latin American Journal of Pharmacy (2016), 35(5), 912-920
Novel stability indicating RP-HPLC method for the simultaneous estimation of moxifloxacin and prednisolone in bulk and their combined dosage form
By Potnuri, Naga Raju; Rao, G. Devala; Prasad, Y. Rajendra
From International Journal of Pharmaceutical Sciences and Research (2015), 6(5), 1965-1973
Development and validation of a new stability indicating reversed phase liquid chromatographic method for the determination of prednisolone acetate and impurities in an ophthalmic suspension
By Marley, Adrian; Stalcup, Apryll M.; Connolly, Damian
From Journal of Pharmaceutical and Biomedical Analysis (2015), 102, 261-266